Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

 
<< vorige    volgende >>
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
           Alle artikelen van de bijbehorende aflevering
                                       Details van artikel 7 van 10 gevonden artikelen
 
 
  Monoclonal Antibodies for Septic Shock: In or Out of the Barn Door? * * This is a preliminary report on a joint Thomas Jefferson University Hospital/University Hospital Consortium project to evaluate the use of antiendotoxin monoclonal antibodies. Forthcoming clinical guidelines for their use, in final draft form at this writing, have not been evaluated, but given the issue’s timeliness the authors offer their findings for discussion. The drug use surveillance component of this project was supported in part by Centocor, Inc (Malvern, Penn), which manufactures Centoxin, an antiendotoxin monoclonal antibody. The authors have collectively signed a financial disclosure statement and affirm the absence of any financial conflict of interest. The opinions expressed herein are solely those of the authors and not the University Hospital Consortium or any of its members. The $3,750 cost of the human monoclonal antibody against endotoxin is derived from the market price in Germany, the United Kingdom, and the Netherlands; the final U.S. price has not been determined. Scrip World Pharmaceutical News Jul 10, 1991, no. 1632.
 
 
Titel: Monoclonal Antibodies for Septic Shock: In or Out of the Barn Door? * * This is a preliminary report on a joint Thomas Jefferson University Hospital/University Hospital Consortium project to evaluate the use of antiendotoxin monoclonal antibodies. Forthcoming clinical guidelines for their use, in final draft form at this writing, have not been evaluated, but given the issue’s timeliness the authors offer their findings for discussion. The drug use surveillance component of this project was supported in part by Centocor, Inc (Malvern, Penn), which manufactures Centoxin, an antiendotoxin monoclonal antibody. The authors have collectively signed a financial disclosure statement and affirm the absence of any financial conflict of interest. The opinions expressed herein are solely those of the authors and not the University Hospital Consortium or any of its members. The $3,750 cost of the human monoclonal antibody against endotoxin is derived from the market price in Germany, the United Kingdom, and the Netherlands; the final U.S. price has not been determined. Scrip World Pharmaceutical News Jul 10, 1991, no. 1632.
Auteur: Nash, David B.
Johnson, Nelda E.
Gottlieb, Jonathan E.
Vlasses, Peter H.
Verschenen in: QRB
Paginering: Jaargang 17 (1991) nr. 10 pagina's 4 p.
Jaar: 1991
Inhoud:
Uitgever: Joint Commission on Accreditation of Healthcare Organizations
Bronbestand: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details van artikel 7 van 10 gevonden artikelen
 
<< vorige    volgende >>
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland